SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy

被引：2

作者：

Sun, Lova ^{[1
]}

Surya, Sanjna ^{[1
]}

Goodman, Noah G. ^{[1
]}

Le, Anh N. ^{[1
]}

Kelly, Gregory ^{[1
]}

Owoyemi, Olutosin ^{[1
]}

Desai, Heena ^{[1
]}

Zheng, Cathy ^{[1
]}

DeLuca, Shannon ^{[1
]}

Good, Madeline L. ^{[1
]}

Hussain, Jasmin ^{[2
]}

Jeffries, Seth D. ^{[1
]}

Kry, Yolanda R. ^{[2
]}

Kugler, Emily M. ^{[1
]}

Mansour, Maikel ^{[2
]}

Ndicu, John ^{[1
]}

Osei-Akoto, Annaclaire ^{[3
]}

Prior, Timothy ^{[2
]}

Pundock, Stacy L. ^{[1
]}

Varughese, Lisa A. ^{[3
]}

Weaver, JoEllen ^{[3
]}

Doucette, Abigail ^{[4
]}

Dudek, Scott ^{[3
]}

Verma, Shefali Setia ^{[3
]}

Gouma, Sigrid ^{[5
]}

Weirick, Madison E. ^{[5
]}

McAllister, Christopher M. ^{[5
]}

Bange, Erin ^{[1
]}

Gabriel, Peter ^{[4
,6
]}

Ritchie, Marylyn ^{[3
]}

Rader, Daniel J. ^{[3
]}

Vonderheide, Robert H. ^{[1
,6
]}

Schuchter, Lynn M. ^{[1
,6
]}

Verma, Anurag ^{[3
]}

Maillard, Ivan ^{[1
,6
]}

Mamtani, Ronac ^{[1
,6
]}

Hensley, Scott E. ^{[5
]}

Gross, Robert ^{[7
]}

Wileyto, E. Paul ^{[8
]}

Huang, Alexander C. ^{[1
,6
]}

Maxwell, Kara N. ^{[1
,3
,6
]}

DeMichele, Angela ^{[1
,6
]}

机构：

[1] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA USA

[2] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA USA

[3] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA USA

[4] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA USA

[5] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA

[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[7] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA USA

[8] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA USA

来源：

JCO ONCOLOGY PRACTICE | 2021年 / 17卷 / 12期

基金：

美国国家卫生研究院;

关键词：

COVID-19; IMPACT;

D O I：

10.1200/OP.21.00113

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PURPOSE Multiple studies have demonstrated the negative impact of cancer care delays during the COVID-19 pandemic, and transmission mitigation techniques are imperative for continued cancer care delivery. We aimed to gauge the effectiveness of these measures at the University of Pennsylvania. METHODS We conducted a longitudinal study of SARS-CoV-2 antibody seropositivity and seroconversion in patients presenting to infusion centers for cancer-directed therapy between May 21, 2020, and October 8, 2020. Participants completed questionnaires and had up to five serial blood collections. RESULTS Of 124 enrolled patients, only two (1.6%) had detectable SARS-CoV-2 antibodies on initial blood draw, and no initially seronegative patients developed newly detectable antibodies on subsequent blood draw(s), corresponding to a seroconversion rate of 0% (95% CI, 0.0 TO 4.1%) over 14.8 person-years of follow up, with a median of 13 health care visits per patient. CONCLUSION These results suggest that patients with cancer receiving in-person care at a facility with aggressive mitigation efforts have an extremely low likelihood of COVID-19 infection. (C) 2021 by American Society of Clinical Oncology

引用

页码：748 / +

页数：9

共 50 条

[21] SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines
Di Giacomo, Anna M.
Giacobini, Gianluca
Anichini, Gabriele
Gandolfo, Claudia
D'alonzo, Vincenzo
Calabro, Luana
Lofiego, Maria F.
Cusi, Maria G.
Maio, Michele
EUROPEAN JOURNAL OF CANCER, 2022, 171 : 143 - 149
[22] SARS-CoV-2 seropositivity in renal transplant patients administered intravenous immunoglobulin
Sim, Beatrice Z.
Sim, Bernice L.
Tunbridge, Matthew J.
Perkins, Griffith Boord
Chai, Cheng Sheng
Coates, Patrick Toby
TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (03)
[23] Immune Responses to SARS-CoV-2 Among Patients With Cancer What Can Seropositivity Tell Us?
Sun, Lova
Warner, Jeremy L.
Parikh, Ravi B.
JAMA ONCOLOGY, 2021, 7 (08) : 1123 - 1125
[24] SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
Ruan, Wenly
Ihekweazu, Faith
Walsh, Seema
Karam, Lina
Wyatt, Allyson
Huyen Nguyen
Kellermayer, Richard
INFLAMMATORY BOWEL DISEASES, 2021, 27 : S44 - S45
[25] SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
Ruan, Wenly
Ihekweazu, Faith
Walsh, Seema
Karam, Lina
Wyatt, Allyson
Nguyen, Huyen
Kellermayer, Richard
GASTROENTEROLOGY, 2021, 160 (03) : S60 - S61
[26] Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
Spencer, Elizabeth A.
Klang, Eyal
Dolinger, Michael
Pittman, Nanci
Dubinsky, Marla C.
INFLAMMATORY BOWEL DISEASES, 2021, 27 (11) : 1862 - 1864
[27] Seroconversion and kinetic of anti SARS-COV-2 antibodies in 25 patients with hematological malignancies WHO recovered from SARS-COV-2 infection
Candoni, Anna
Pizzano, Umberto
Fabris, Martina
Curcio, Francesco
Fanin, Renato
HEMATOLOGICAL ONCOLOGY, 2021, 39 (03) : 428 - 430
[28] Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment
Tavares, A.
Magalhaes, D.
Soares, A.
Laranjinha, J.
Mesquita, A.
Duarte, F.
Abreu, R. C.
Magalhaes, H.
Braga, F.
Sottomayor, C.
Salgado, M.
ANNALS OF ONCOLOGY, 2020, 31 : S1028 - S1028
[29] Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy
Aschele, Carlo
Negru, Maria Emanuela
Pastorino, Alessandro
Cavanna, Luigi
Zagonel, Vittorina
Barone-Adesi, Francesco
Blasi, Livio
JAMA ONCOLOGY, 2021, 7 (02) : 304 - 306
[30] Impfung gegen SARS-CoV-2 bei KrebspatientenVaccination against SARS-CoV-2 in cancer patients
Marie von Lilienfeld-Toal
Christina Rieger
Nicola Giesen
Bernhard Wörmann
Der Onkologe, 2021, 27 : 691 - 696

← 1 2 3 4 5 →